Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Frontier IP ( (GB:FIPP) ).
Frontier IP portfolio company The Vaccine Group has reported that its vaccine candidate against the zoonotic pig disease Streptococcus suis outperformed a leading commercial rival in challenge trials run by UK contract research organisation Moredun Scientific. The study showed that the firm’s bovine herpesvirus (BoHV-4) delivery platform is effective beyond cattle, works against both bacterial and viral pathogens, and can protect against multiple S. suis serotypes, reinforcing the broad applicability of its vaccine technology. The S. suis programme, which has benefited from collaborations in China and funding from Innovate UK, sits alongside a separate partnership with Spanish animal health group Syva on another S. suis vaccine, while The Vaccine Group is also in discussions with major animal health companies over commercial development of its bovine respiratory syncytial virus candidates for cattle, potentially strengthening Frontier IP’s position in the animal health innovation market.
The most recent analyst rating on (GB:FIPP) stock is a Sell with a £13.00 price target. To see the full list of analyst forecasts on Frontier IP stock, see the GB:FIPP Stock Forecast page.
Spark’s Take on GB:FIPP Stock
According to Spark, TipRanks’ AI Analyst, GB:FIPP is a Neutral.
The score is held down primarily by weak financial performance (losses and persistent cash burn) and bearish technicals (below major moving averages with negative MACD). Valuation provides limited support due to negative earnings, partially offset by generally positive corporate updates and successful fundraising activity.
To see Spark’s full report on GB:FIPP stock, click here.
More about Frontier IP
Frontier IP Group plc is a specialist in commercialising intellectual property, working with spin-out companies to turn academic and scientific innovations into marketable products and services. The Group builds a portfolio of equity stakes and licence income by actively supporting early-stage businesses, helping them secure funding and engage with industrial partners so that new technologies meet real-world commercial needs.
Average Trading Volume: 138,712
Technical Sentiment Signal: Sell
Current Market Cap: £10.21M
For an in-depth examination of FIPP stock, go to TipRanks’ Overview page.